Diseases & Disorders
(G05)
IRS Verified
DX Registered
PRECISION MEDICINE ACTION FOR CANCER
Financial strength (30%)
37/100
Reliability (20%)
64/100
Effectiveness (25%)
50/100
Impact (25%)
75/100
52
CharityAI™ Score
out of 100
Mission Statement
To conduct innovative, high-impact research in precision medicine with the goal to improve the prognosis and care of patients with breast cancer and other solid tumors while fostering education for the next generation of investigators and the broader community.
Financial Overview — FY 2025
$50K
Total Revenue
$14K
Total Expenses
$0
Net Assets
15
Employees
Revenue Sources
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
0.00x
Liability-to-Asset
N/A
Revenue Diversification
60.0%
Executive Compensation
$0
Compared with Peers
Peer comparison is not available for this organization.
CharityAI™ Evaluation — 2025
52 / 10037
Financial
49
Reliability
50
Effectiveness
75
Impact
Financial Strength (30%)
37
Reliability & Transparency (20%)
49
Program Effectiveness (25%)
50
Impact & Outcomes (25%)
75
270 served annually
$55 per beneficiary
4 programs
15 staff
Form 990 on File 80% Data Complete
Impact
4 programs| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Training of young oncologists on the use of liquid biopsy for cancer management | 20 | $0.05 | — | Lifetime |
| Webinar on liquid biopsy for metastatic breast cancer management | 100 | $10.00 | — | Per Year |
| Co-organization of a conference on precision medicine | 100 | $10.00 | — | Per Year |
| Organization of a workshop on liquid biopsy use for breast cancer care | 50 | $200.00 | — | Per Year |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.